Compass Pathways to Attend Needham Virtual Healthcare Conference on April 14, 2026

Audio By Carbonatix

LONDON & NEW YORK--(BUSINESS WIRE)--Apr 8, 2026--

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Needham Virtual Healthcare Conference on April 14, 2026 and will participate in a fireside chat at 12:45 pm ET.

A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event.

About Compass Pathways

Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational COMP360 synthetic psilocybin treatment, potentially a first in class treatment. COMP360 has Breakthrough Therapy designation from the US Food and Drug Administration (FDA) and has received Innovative Licensing and Access Pathway (ILAP) designation in the UK for treatment-resistant depression (TRD).

Compass is headquartered in London, UK, with offices in New York in the US. We envision a world where mental health means not just the absence of illness but the ability to thrive.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260408635150/en/

CONTACT: EnquiriesMedia: Dana Sultan-Rothman,[email protected]

Investors: Stephen Schultz,[email protected], +1 401 290 7324

KEYWORD: NEW YORK EUROPE UNITED STATES UNITED KINGDOM NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY ALTERNATIVE MEDICINE FDA OTHER HEALTH HEALTH PHARMACEUTICAL MENTAL HEALTH OTHER SCIENCE RESEARCH SCIENCE CLINICAL TRIALS

SOURCE: Compass Pathfinder Limited

Copyright Business Wire 2026.

PUB: 04/08/2026 06:30 AM/DISC: 04/08/2026 06:32 AM

http://www.businesswire.com/news/home/20260408635150/en